REFERENCES 1. ECDC. Surveillance of healthcareassociated infections in Europe, 2007. Stockholm: European Centre for Disease Prevention and Control; 2012. 2. Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen‐Bridson K, Morrell G, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37(10):doi:10.1016/j.ajic.2009.10.001. 3. Koulenti D, Tsigou E, Rello J. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU‐VAP/CAP study. Eur J Clin Microbiol Infect Dis. 2016:doi:10.1007/s10096‐016‐2703‐z. 4. Bekaert M, Timsit JF, Vansteelandt S, Depuydt P, Vesin A, Garrouste‐Orgeas M, et al. Attributable mortality of ventilator‐associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med. 2011;184(10):doi:10.1164/rccm.201105‐0867OC. 5. Melsen WG, Rovers MM, Groenwold RH, Bergmans DC, Camus C, Bauer TT, et al. Attributable mortality of ventilator‐associated pneumonia: a meta‐analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013;13(8):doi:10.1016/S1473‐3099(13)70081‐1. 6. Muscedere JG, Martin CM, Heyland DK. The impact of ventilator‐associated pneumonia on the Canadian health care system. J Crit Care. 2008;23(1):doi:10.1016/j.jcrc.2007.11.012. 7. Timsit JF, Zahar JR, Chevret S. Attributable mortality of ventilator‐associated pneumonia. Curr Opin Crit Care. 2011;17(5):doi:10.1097/MCC.0b013e32834a5ae9. 8. Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, et al. Burden of Six Healthcare‐Associated Infections on European Population Health: Estimating Incidence‐Based Disability‐ Adjusted Life Years through a Population Prevalence‐Based Modelling Study. PLoS Med. 2016;13(10):doi:10.1371/journal.pmed.1002150. 9. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, et al. Incidence of and risk factors for ventilator‐associated pneumonia in critically ill patients. Ann Intern Med. 1998;129(6):doi:433‐40. 10. Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, et al. Silver‐coated endotracheal tubes and incidence of ventilator‐associated pneumonia: the NASCENT randomized trial. JAMA. 2008;300(7):doi:10.1001/jama.300.7.805. 11. Tejerina E, Frutos‐Vivar F, Restrepo MI, Anzueto A, Abroug F, Palizas F, et al. Incidence, risk factors, and outcome of ventilator‐associated pneumonia. J Crit Care. 2006;21(1):doi:10.1016/j.jcrc.2005.08.005. 12. Alp E, Guven M, Yildiz O, Aygen B, Voss A, Doganay M. Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: a prospective study. Ann Clin Microbiol Antimicrob. 2004;3:doi:10.1186/1476‐0711‐3‐17. 13. Krag M, Perner A, Wetterslev J, Wise MP, Hylander Moller M. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta‐analysis and trial sequential analysis. Intensive Care Med. 2014;40(1):doi:10.1007/s00134‐013‐3125‐ 3. 14. Sofianou DC, Constandinidis TC, Yannacou M, Anastasiou H, Sofianos E. Analysis of risk factors for ventilator‐associated pneumonia in a multidisciplinary intensive care unit. Eur J Clin Microbiol Infect Dis. 2000;19(6):doi:460‐3. 15. Apostolopoulou E, Bakakos P, Katostaras T, Gregorakos L. Incidence and risk factors for ventilator‐ associated pneumonia in 4 multidisciplinary intensive care units in Athens, Greece. Respir Care. 2003;48(7):doi:681‐8. 16. Pawar M, Mehta Y, Khurana P, Chaudhary A, Kulkarni V, Trehan N. Ventilator‐associated pneumonia: Incidence, risk factors, outcome, and microbiology. J Cardiothorac Vasc Anesth. 2003;17(1):doi:10.1053/jcan.2003.4. 4 85 Risk factors for VAP using flexible methods
RkJQdWJsaXNoZXIy MTk4NDMw